NCT07528300 Effect of Battlefield Acupuncture on Pain Control During Inpatient Treatment of Exertional Rhabdomyolysis
| NCT ID | NCT07528300 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Tripler Army Medical Center |
| Condition | Rhabdomyolysis |
| Study Type | INTERVENTIONAL |
| Enrollment | 36 participants |
| Start Date | 2023-04-24 |
| Primary Completion | 2028-04-24 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 36 participants in total. It began in 2023-04-24 with a primary completion date of 2028-04-24.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Patients admitted with exertional rhabdomyolysis will be offered treatment with battlefield acupuncture for pain management and compared with patient's pain levels and pain medication requirements with those patients who declined battlefield acupuncture.
Eligibility Criteria
Inclusion Criteria: * Rhabdomyolysis * chooses battlefield acupuncture Exclusion Criteria: * Greater than 72 hours from onset of symptoms * younger than 18 years of age * declines battlefield acupuncture * no pain
Contact & Investigator
Chelsea W Tagawa, MD
PRINCIPAL INVESTIGATOR
Tripler Army Medical Center
Frequently Asked Questions
Who can join the NCT07528300 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 99 Years, studying Rhabdomyolysis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07528300 currently recruiting?
Yes, NCT07528300 is actively recruiting participants. Contact the research team at chelsea.w.tagawa.civ@health.mil for enrollment information.
Where is the NCT07528300 trial being conducted?
This trial is being conducted at TAMC, United States.
Who is sponsoring the NCT07528300 clinical trial?
NCT07528300 is sponsored by Tripler Army Medical Center. The principal investigator is Chelsea W Tagawa, MD at Tripler Army Medical Center. The trial plans to enroll 36 participants.